Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.085 AUD
−645.80 M AUD
1.75 B AUD
569.33 M
About HEALIUS LIMITED
Sector
Industry
CEO
Paul Anderson
Website
Headquarters
Sydney
Founded
1994
ISIN
AU0000033359
FIGI
BBG000BBDQK8
Healius Ltd. engages in the provision of healthcare technology solutions. It operates through the following segments: Pathology, Imaging, and Other. The Pathology segment provides pathology services. The Imaging segment focuses on imaging services from stand-alone imaging sites, hospitals, and medical centers. The Other segment consists of corporate functions. The company was founded by Edmund Gregory Thomas Bateman in 1985 and is headquartered in St. Leonards, Australia.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of HLS is 1.340 AUD — it has increased by 2.66% in the past 24 hours. Watch HEALIUS LIMITED stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on ASX exchange HEALIUS LIMITED stocks are traded under the ticker HLS.
HLS stock has fallen by −16.15% compared to the previous week, the month change is a −22.64% fall, over the last year HEALIUS LIMITED has showed a 2.84% increase.
We've gathered analysts' opinions on HEALIUS LIMITED future price: according to them, HLS price has a max estimate of 1.75 AUD and a min estimate of 1.05 AUD. Watch HLS chart and read a more detailed HEALIUS LIMITED stock forecast: see what analysts think of HEALIUS LIMITED and suggest that you do with its stocks.
HLS stock is 3.01% volatile and has beta coefficient of 1.38. Track HEALIUS LIMITED stock price on the chart and check out the list of the most volatile stocks — is HEALIUS LIMITED there?
Today HEALIUS LIMITED has the market capitalization of 980.28 M, it has decreased by −1.50% over the last week.
Yes, you can track HEALIUS LIMITED financials in yearly and quarterly reports right on TradingView.
HEALIUS LIMITED is going to release the next earnings report on Feb 25, 2025. Keep track of upcoming events with our Earnings Calendar.
HLS earnings for the last half-year are 0.01 AUD per share, whereas the estimation was 0.01 AUD, resulting in a 14.16% surprise. The estimated earnings for the next half-year are −0.01 AUD per share. See more details about HEALIUS LIMITED earnings.
HEALIUS LIMITED revenue for the last half-year amounts to 897.60 M AUD, despite the estimated figure of 881.08 M AUD. In the next half-year revenue is expected to reach 913.74 M AUD.
HLS net income for the last half-year is −10.00 M AUD, while the previous report showed −635.80 M AUD of net income which accounts for 98.43% change. Track more HEALIUS LIMITED financial stats to get the full picture.
As of Nov 25, 2024, the company has 10.50 K employees. See our rating of the largest employees — is HEALIUS LIMITED on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. HEALIUS LIMITED EBITDA is 346.70 M AUD, and current EBITDA margin is 19.85%. See more stats in HEALIUS LIMITED financial statements.
Like other stocks, HLS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade HEALIUS LIMITED stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So HEALIUS LIMITED technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating HEALIUS LIMITED stock shows the strong sell signal. See more of HEALIUS LIMITED technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.